Antidepressants in bipolar depression: The clinical debate

被引：16
|
作者：
Ghaemi, S. Nassir [1 ]
机构：
[1] Tufts Univ, Dept Psychiat, Tufts Med Ctr, Sch Med, Boston, MA 02111 USA
来源：
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY | 2012年 / 46卷 / 04期
关键词：
MOOD STABILIZERS; DOUBLE-BLIND; II DISORDER; MONOTHERAPY; VENLAFAXINE; EFFICACY; SAFETY; DISCONTINUATION; FLUOXETINE; SERTRALINE;
D O I：
10.1177/0004867412441035
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：298 / 301
页数：4
相关论文
共 50 条
  • [21] A quantitative review on outcome-to-antidepressants in melancholic unipolar depression
    Valerio, Marina P.
    Szmulewicz, Alejandro G.
    Martino, Diego J.
    PSYCHIATRY RESEARCH, 2018, 265 : 100 - 110
  • [22] Antidepressants in Type II Versus Type I Bipolar Depression A Randomized Discontinuation Trial
    Voehringer, Paul A.
    Ostacher, Michael J.
    El-Mallakh, Rif S.
    Holtzman, Niki S.
    Thommi, Sairah B.
    Whitham, Elizabeth A.
    Sullivan, Matthew C.
    Baldassano, Claudia F.
    Goodwin, Fredrick K.
    Baldessarini, Ross J.
    Ghaemi, S. Nassir
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2015, 35 (05) : 605 - 608
  • [23] Treatment of Depression in the Elderly: A Review of the Recent Literature on the Efficacy of Single- Versus Dual-Action Antidepressants
    Mukai, Yuki
    Tampi, Rajesh R.
    CLINICAL THERAPEUTICS, 2009, 31 (05) : 945 - 961
  • [24] Antidepressant monotherapy and combination of antidepressants in the treatment of resistant depression in current clinical practice: A retrospective study
    Bares, Martin
    Novak, Tomas
    Kopecek, Miloslav
    Stopkova, Pavla
    Hoeschl, Cyril
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2010, 14 (04) : 303 - 308
  • [25] Balancing benefits and harms of treatments for acute bipolar depression
    Ketter, Terence A.
    Miller, Shefali
    Dell'Osso, Bernardo
    Calabrese, Joseph R.
    Frye, Mark A.
    Citrome, Leslie
    JOURNAL OF AFFECTIVE DISORDERS, 2014, 169 : S24 - S33
  • [26] Relationship between placebo response rate and clinical trial outcome in bipolar depression
    Iovieno, Nadia
    Nierenberg, Andrew A.
    Parkin, Susannah R.
    Kim, Daniel Ju Hyung
    Walker, Rosemary S. W.
    Fava, Maurizio
    Papakostas, George I.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2016, 74 : 38 - 44
  • [27] Benefits and limitations of antidepressants and traditional mood stabilizers for treatment of bipolar depression
    Goldberg, JF
    Ghaemi, SN
    BIPOLAR DISORDERS, 2005, 7 : 3 - 12
  • [28] Comparison of Antidepressant Responses in Patients with Bipolar vs. Unipolar Depression: A Meta-Analytic Review
    Vazquez, G.
    Tondo, L.
    Baldessarini, R. J.
    PHARMACOPSYCHIATRY, 2011, 44 (01) : 21 - 26
  • [29] Quetiapine monotherapy for bipolar depression
    Janicak, Philip G.
    Rado, Jeffrey T.
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (10) : 1643 - 1651
  • [30] Pharmacotherapy for the Treatment of Acute Bipolar II Depression: Current Evidence
    Swartz, Holly A.
    Thase, Michael E.
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (03) : 356 - 366
12345